Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.

Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK.

Gastroenterology. 2013 Jul;145(1):79-86.e1. doi: 10.1053/j.gastro.2013.03.008. Epub 2013 Mar 15.

2.

Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.

Guthikonda A, Cotton CC, Madanick RD, Spacek MB, Moist SE, Ferrell K, Dellon ES, Shaheen NJ.

Am J Gastroenterol. 2017 Jan;112(1):87-94. doi: 10.1038/ajg.2016.451. Epub 2016 Oct 11.

PMID:
27725648
3.

Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.

Cotton CC, Wolf WA, Overholt BF, Li N, Lightdale CJ, Wolfsen HC, Pasricha S, Wang KK, Shaheen NJ; AIM Dysplasia Trial Group.

Gastroenterology. 2017 Sep;153(3):681-688.e2. doi: 10.1053/j.gastro.2017.05.044. Epub 2017 Jun 1.

PMID:
28579538
4.

Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.

Wani S, Rubenstein JH, Vieth M, Bergman J.

Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1. Review.

PMID:
27702561
5.

Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.

Orman ES, Li N, Shaheen NJ.

Clin Gastroenterol Hepatol. 2013 Oct;11(10):1245-55. doi: 10.1016/j.cgh.2013.03.039. Epub 2013 May 2. Review.

6.

Gender differences in remission of esophageal intestinal metaplasia after radiofrequency ablation.

Qumseya B, David W, McCrum M, Dong Y, Raimondo M, Woodward TA, Wallace MB, Wolfsen HC.

Am J Gastroenterol. 2014 Mar;109(3):369-74. doi: 10.1038/ajg.2013.454. Epub 2014 Jan 7.

PMID:
24394753
7.

Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.

van Vilsteren FG, Alvarez Herrero L, Pouw RE, Visser M, Ten Kate FJ, van Berge Henegouwen MI, Schoon EJ, Weusten BL, Bergman JJ.

Endoscopy. 2012 Dec;44(12):1096-104. doi: 10.1055/s-0032-1325731. Epub 2012 Oct 29.

PMID:
23108809
8.

Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.

Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B.

Endoscopy. 2012 Dec;44(12):1105-13. doi: 10.1055/s-0032-1310155. Epub 2012 Sep 11.

PMID:
22968641
9.

Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.

van Vilsteren FG, Alvarez Herrero L, Pouw RE, Schrijnders D, Sondermeijer CM, Bisschops R, Esteban JM, Meining A, Neuhaus H, Parra-Blanco A, Pech O, Ragunath K, Rembacken B, Schenk BE, Visser M, ten Kate FJ, Meijer SL, Reitsma JB, Weusten BL, Schoon EJ, Bergman JJ.

Endoscopy. 2013 Jul;45(7):516-25. doi: 10.1055/s-0032-1326423. Epub 2013 Apr 11.

PMID:
23580412
10.

Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.

Cotton CC, Wolf WA, Pasricha S, Li N, Madanick RD, Spacek MB, Ferrell K, Dellon ES, Shaheen NJ.

Gastrointest Endosc. 2015;81(6):1362-9. doi: 10.1016/j.gie.2014.12.029. Epub 2015 Mar 24.

11.

Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.

Chadwick G, Groene O, Markar SR, Hoare J, Cromwell D, Hanna GB.

Gastrointest Endosc. 2014 May;79(5):718-731.e3. doi: 10.1016/j.gie.2013.11.030. Epub 2014 Jan 23. Review.

PMID:
24462170
12.

Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation.

Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, Capiak KM, Lightdale CJ, Abrams JA.

Dig Dis Sci. 2011 Jul;56(7):1996-2000. doi: 10.1007/s10620-011-1680-4. Epub 2011 Apr 6.

13.

Comparison of endoscopic treatment modalities for Barrett's neoplasia.

David WJ, Qumseya BJ, Qumsiyeh Y, Heckman MG, Diehl NN, Wallace MB, Raimondo M, Woodward TA, Wolfsen HC.

Gastrointest Endosc. 2015 Nov;82(5):793-803.e3. doi: 10.1016/j.gie.2015.03.1979. Epub 2015 Jun 10.

PMID:
26071064
14.

Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.

Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P, Devière J, Neuhaus H, Bergman JJ.

Clin Gastroenterol Hepatol. 2010 Jan;8(1):23-9. doi: 10.1016/j.cgh.2009.07.003. Epub 2009 Aug 11.

PMID:
19602454
15.

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.

Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, Bronner MP, Goldblum JR, Bennett AE, Mashimo H, Rothstein RI, Gordon SR, Edmundowicz SA, Madanick RD, Peery AF, Muthusamy VR, Chang KJ, Kimmey MB, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Dumot JA, Falk GW, Galanko JA, Jobe BA, Hawes RH, Hoffman BJ, Sharma P, Chak A, Lightdale CJ.

Gastroenterology. 2011 Aug;141(2):460-8. doi: 10.1053/j.gastro.2011.04.061. Epub 2011 May 6.

16.

Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.

Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG.

Gastrointest Endosc. 2013 Feb;77(2):190-9. doi: 10.1016/j.gie.2012.10.013.

PMID:
23317687
17.

Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.

Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ.

Gastrointest Endosc. 2012 Oct;76(4):733-9. doi: 10.1016/j.gie.2012.04.459. Epub 2012 Jun 23.

18.

The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.

Johnson CS, Louie BE, Wille A, Dunst CM, Worrell SG, DeMeester SR, Reynolds J, Dixon J, Lipham JC, Lada M, Peters JH, Watson TJ, Farivar AS, Aye RW.

J Gastrointest Surg. 2015 May;19(5):799-805. doi: 10.1007/s11605-015-2783-6. Epub 2015 Mar 5.

PMID:
25740341
19.

Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.

Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, Green S, Miah H, Smart HL, Bhandari P, Smith LA, Willert R, Fullarton G, Morris J, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O'Toole D, Cheong E, Direkze NC, Ang Y, Novelli M, Banks MR, Lovat LB.

Gastroenterology. 2013 Jul;145(1):87-95. doi: 10.1053/j.gastro.2013.03.045. Epub 2013 Mar 28.

PMID:
23542069
20.

Risk of recurrence of Barrett's esophagus after successful endoscopic therapy.

Krishnamoorthi R, Singh S, Ragunathan K, A Katzka D, K Wang K, G Iyer P.

Gastrointest Endosc. 2016 Jun;83(6):1090-1106.e3. doi: 10.1016/j.gie.2016.02.009. Epub 2016 Feb 20. Review.

Supplemental Content

Support Center